GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) » Definitions » Shares Outstanding (EOP)

Zhejiang Hisoar Pharmaceutical Co (SZSE:002099) Shares Outstanding (EOP) : 1,619 Mil (As of Sep. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Zhejiang Hisoar Pharmaceutical Co Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Zhejiang Hisoar Pharmaceutical Co's shares outstanding for the quarter that ended in Sep. 2024 was 1,619 Mil.

Zhejiang Hisoar Pharmaceutical Co's quarterly shares outstanding stayed the same from Jun. 2024 (1,619 Mil) to Sep. 2024 (1,619 Mil).

Zhejiang Hisoar Pharmaceutical Co's annual shares outstanding stayed the same from Dec. 2022 (1,619 Mil) to Dec. 2023 (1,619 Mil).


Zhejiang Hisoar Pharmaceutical Co Shares Outstanding (EOP) Historical Data

The historical data trend for Zhejiang Hisoar Pharmaceutical Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Hisoar Pharmaceutical Co Shares Outstanding (EOP) Chart

Zhejiang Hisoar Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,618.72 1,618.72 1,618.72 1,618.72 1,618.72

Zhejiang Hisoar Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,618.72 1,618.72 1,618.72 1,618.72 1,618.72

Competitive Comparison of Zhejiang Hisoar Pharmaceutical Co's Shares Outstanding (EOP)

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Hisoar Pharmaceutical Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Hisoar Pharmaceutical Co's Shares Outstanding (EOP) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Hisoar Pharmaceutical Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Zhejiang Hisoar Pharmaceutical Co's Shares Outstanding (EOP) falls into.



Zhejiang Hisoar Pharmaceutical Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Zhejiang Hisoar Pharmaceutical Co  (SZSE:002099) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Zhejiang Hisoar Pharmaceutical Co Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Zhejiang Hisoar Pharmaceutical Co's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Hisoar Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 507 Shifu Avenue, Taizhou International Business Plaza, Block A, 8F, Taizhou, Zhejiang, CHN, 318000
Zhejiang Hisoar Pharmaceutical Co Ltd is a China-based company engages in the production of specialty raw materials, preparations and fine chemicals, dyes and dye intermediates. Its products include Clindamycin hydrochloride, Clindamycin phosphate, Florfenicol, Atova, Thiamphenicol, and Riglinay.
Executives
Wang Yang Chao Director
Yang Si Wei Directors, executives
Xu Guo Rui Executives
Xu Hua Qing Secretary Dong
Hong Ming Director
Guo Min Long Director
Li Hong Ming Executives
Jiang Ru Dong Securities Affairs Representative
Mao Wen Hua Executives
Sun Yang Director
Li Wei Jin Director
Luo Yu Hong Director
Pan Qing Hua Directors, executives
Chen Zheng Hua Supervisors
Jia Qiang Executives, directors

Zhejiang Hisoar Pharmaceutical Co Headlines

No Headlines